{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:22:46Z","timestamp":1791958966776,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1067\/mjd.2003.450","type":"journal-article","created":{"date-parts":[[2003,7,16]],"date-time":"2003-07-16T14:38:44Z","timestamp":1058366324000},"page":"145-147","source":"Crossref","is-referenced-by-count":50,"title":["An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis"],"prefix":"10.1067","volume":"49","author":[{"given":"Azin","family":"Meshkinpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joannie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2003.450_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mjd.2001.110902","article-title":"?Topical immunomodulators??","volume":"44","author":"Nghiem","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1067\/mjd.2003.450_bib2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1067\/mjd.2001.109811","article-title":"Current management and therapy of atopic dermatitis","volume":"44","author":"Tofte","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.450_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/14656566.2.7.1167","article-title":"Topical tacrolimus for the treatment of inflammatory skin diseases","volume":"2","author":"Assmann","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1067\/mjd.2003.450_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1345\/aph.10342","article-title":"Topical tacrolimus in the treatment of atopic dermatitis","volume":"35","author":"Gianni","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1067\/mjd.2003.450_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2133.1986.tb04878.x","article-title":"Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), micaonazole and hydrocortisone","volume":"114","author":"Faergemann","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2003.450_bib6","first-page":"1","article-title":"Seborrheic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies","volume":"167","author":"Bergbrant","year":"1991","journal-title":"Acta Derm Venereol Suppl (Stockh"},{"key":"10.1067\/mjd.2003.450_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2133.2001.04082.x","article-title":"Seborrheic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry","volume":"144","author":"Faergemann","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2003.450_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1398-9995.1999.00089.x","article-title":"Pityrosporum species as a cause of allergy and infection","volume":"54","author":"Faergemann","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mjd.2003.450_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1523-1747.2001.01321.x","article-title":"The effects of Malassezia yeasts on cytokine production by human keratinocytes","volume":"116","author":"Watanabe","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2003.450_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.1998.02362.x","article-title":"Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast","volume":"139","author":"Parry","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2003.450_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-3083.1996.tb00605.x","article-title":"Atopic dermatitis","volume":"7","author":"Bos","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1067\/mjd.2003.450_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2249.1995.tb05525.x","article-title":"IL-8\/IL-8 receptor expression psoriasis response systemic tacrolimus (FK506)","volume":"99","author":"Lemster","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2003.450_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000236745","article-title":"Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoids","volume":"104","author":"Mori","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1067\/mjd.2003.450_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(94)92855-X","article-title":"Tacrolimus ointment for atopic eczema","volume":"344","author":"Nakagawa","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.450_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0162-3109(00)00187-9","article-title":"Applications of tacrolimus for the treatment of skin disorders","volume":"47","author":"Assman","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1067\/mjd.2003.450_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199709183371203","article-title":"A short-term trial of tacrolimus ointment for atopic dermatitis","volume":"337","author":"Ruzicka","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2003.450_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1254\/fpj.112.221","article-title":"Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice","volume":"112","author":"Sengoku","year":"1998","journal-title":"Folia Pharmacol Jpn"},{"key":"10.1067\/mjd.2003.450_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/1523-1747.ep12456939","article-title":"Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases?","volume":"98","author":"Meingassner","year":"1992","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203008065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203008065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T07:51:26Z","timestamp":1552809086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962203008065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S0190962203008065"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2003.450","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}